Posted on: 28th September 2017
NIIMBL – a public-private US consortium dedicated to the advancement of biopharmaceutical manufacturing innovation – will enjoy representation at both Steering Committee and Workstream level. As a Phorum member, NIIMBL will leverage BPOG’s recently published Technology Roadmap to prioritize activities and inform project calls for the NIIMBL community.
BPOG will continue to own and facilitate the Technology Roadmap and, in collaboration with NIIMBL, will facilitate the development and publication of a US-specific component that is eventually expected to form part of the global Roadmap document. The US-specific Roadmap will focus on economic, regulatory, workforce development and research challenges facing the US biopharmaceutical manufacturing industry.
Kelvin Lee, NIIMBL Director, said, “The partnership with BPOG enables us to leverage and synergize with the established global biopharmaceutical Technology Roadmap to help NIIMBL prioritize technology development in the short term. In the longer term, the collaboration will help NIIMBL develop a US-specific Roadmap component that will further facilitate our mission to accelerate US biopharmaceutical manufacturing innovation.
The partnership with NIIMBL represents an exciting next step on the path towards BPOG’s ambition to become the ‘go to’ place for biopharmaceutical road mapping. In addition to plans to broaden the scope of future editions of the Technology Roadmap to include emerging products, vaccines and blood products, the Technology Roadmap Phorum also aims to leverage its knowledge and experience of road mapping processes to assist other regional innovation hubs to localize their own roadmaps. In turn, the partnership with BPOG will enable NIIMBL to focus resources on the advancement of manufacturing technologies and standards to enhance patient access to biopharmaceutical medicines. NIIMBL is the largest public-private partnership in biopharmaceutical manufacturing, and is comprised of industry, academic and government partners with more than $200 million (USD) of resources to advance technology and workforce development activities.
According to Steve Jones, BPOG Director: “We are delighted that NIIMBL has chosen to use the BPOG Technology Roadmap as a guide to inform technology developments. Furthermore, we look forward to working with NIIMBL to explore the issues and challenges facing the US biopharmaceutical manufacturing industry.”
For more information, contact Steve Jones at email@example.com